Skip to main content

Advertisement

Log in

Trans-fatty acids and nonlipid risk factors

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

Consumption of industrially produced trans-fatty acids (TFA) is associated with substantial risk of coronary heart disease (CHD). The magnitude of this relationship, as well as emerging associations with end points such as diabetes and sudden cardiac death, cannot be fully explained by the well-established adverse effects of TFA on serum lipids. We review the evidence for effects of TFA intake on nonlipid risk factors. Based on evidence from randomized controlled trials, observational studies, animal experiments, and in vitro studies, these include effects on systemic inflammation, endothelial dysfunction, visceral adiposity, insulin resistance, and arrhythmic risk. The types and strength of evidence for each of these nonlipid effects varies, but the overall constellation of findings is qualitatively and quantitatively unique among dietary fats. The multiple adverse effects and implicated pathways are consistent with the observed strong associations of TFA consumption with CHD risk. These nonlipid effects also explain why TFA consumption may adversely impact other non-CHD diseases and end points.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Mozaffarian D, Katan MB, Ascherio A, et al.: Trans fatty acids and cardiovascular disease. N Engl J Med 2006, 354:1601–1613.

    Article  PubMed  CAS  Google Scholar 

  2. Mozaffarian D, Abdollahi M, Campos H, et al.: Consumption of trans fats and estimated effects on coronary heart disease in Iran. Eur J Clin Nutr 2007, 61:1004–1010.

    Article  PubMed  CAS  Google Scholar 

  3. Mozaffarian D, Clarke R: Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr 2009, 63(Suppl 2):S22–S33.

    Article  PubMed  CAS  Google Scholar 

  4. Allison DB, Egan SK, Barraj LM, et al.: Estimated intakes of trans fatty and other fatty acids in the US population. J Am Diet Assoc 1999, 99:166–174; quiz 175–176.

    Article  PubMed  CAS  Google Scholar 

  5. Micha R, Mozaffarian D: Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat Rev Endocrinol 2009, 5:335–344.

    Article  PubMed  CAS  Google Scholar 

  6. Baer DJ, Judd JT, Clevidence BA, et al.: Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004, 79:969–973.

    PubMed  CAS  Google Scholar 

  7. Han SN, Leka LS, Lichtenstein AH, et al.: Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. J Lipid Res 2002, 43:445–452.

    PubMed  CAS  Google Scholar 

  8. Lichtenstein AH, Erkkilä AT, Lamarche B, et al.: Influence of hydrogenated fat and butter on CVD risk factors: remnant-like particles, glucose and insulin, blood pressure and C-reactive protein. Atherosclerosis 2003, 171:97–107.

    Article  PubMed  CAS  Google Scholar 

  9. Dlouhy P, Kucera P, Kraml P, et al.: Short-term dietary intake of C18:1 trans fatty acids decreases the function of cellular immunity in healthy young men. Ann Nutr Metab 2008, 53:129–136.

    Article  PubMed  CAS  Google Scholar 

  10. Mozaffarian D, Pischon T, Hankinson SE, et al.: Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 2004, 79:606–612.

    PubMed  CAS  Google Scholar 

  11. Lopez-Garcia E, Schulze MB, Meigs JB, et al.: Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 2005, 135:562–566.

    PubMed  CAS  Google Scholar 

  12. Esmaillzadeh A, Azadbakht L: Home use of vegetable oils, markers of systemic inflammation, and endothelial dysfunction among women. Am J Clin Nutr 2008, 88:913–921.

    PubMed  CAS  Google Scholar 

  13. Mozaffarian D, Rimm EB, King IB, et al.: Trans fatty acids and systemic inflammation in heart failure. Am J Clin Nutr 2004, 80:1521–1525.

    PubMed  CAS  Google Scholar 

  14. Kummerow FA, Zhou Q, Mahfouz MM, et al.: Trans fatty acids in hydrogenated fat inhibited the synthesis of the polyunsaturated fatty acids in the phospholipid of arterial cells. Life Sci 2004, 74:2707–2723.

    Article  PubMed  CAS  Google Scholar 

  15. Decsi T, Boehm G, Tjoonk HM, et al.: Trans isomeric octadecenoic acids are related inversely to arachidonic acid and DHA and positively related to mead acid in umbilical vessel wall lipids. Lipids 2002, 37:959–965.

    Article  PubMed  CAS  Google Scholar 

  16. Innis SM: Trans fatty intakes during pregnancy, infancy and early childhood. Atheroscler Suppl 2006, 7:17–20.

    Article  PubMed  CAS  Google Scholar 

  17. Kummerow FA, Mahfouz MM, Zhou Q: Trans fatty acids in partially hydrogenated soybean oil inhibit prostacyclin release by endothelial cells in presence of high level of linoleic acid. Prostaglandins Other Lipid Mediat 2007, 84:138–153.

    Article  PubMed  CAS  Google Scholar 

  18. Mahfouz MM, Kummerow FA: Hydrogenated fat high in trans monoenes with an adequate level of linoleic acid has no effect on prostaglandin synthesis in rats. J Nutr 1999, 129:15–24.

    PubMed  CAS  Google Scholar 

  19. Balazy M, Chemtob S: Trans-arachidonic acids: new mediators of nitro-oxidative stress. Pharmacol Ther 2008, 119:275–290.

    Article  PubMed  CAS  Google Scholar 

  20. Vanden Heuvel JP: Diet, fatty acids, and regulation of genes important for heart disease. Curr Atheroscler Rep 2004, 6:432–440.

    Article  Google Scholar 

  21. Koppe SP, Elias M, Moseley RH, and Green RM: Trans fat feeding results in higher serum alanine aminotransferase and increased insulin resistance compared with a standard murine high-fat diet. Am J Physiol Gastrointest Liver Physiol 2009, 297:G378–G384.

    Article  PubMed  CAS  Google Scholar 

  22. de Roos NM, Bots ML, Katan MB: Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler Thromb Vasc Biol 2001, 21:1233–1237.

    Article  PubMed  Google Scholar 

  23. de Roos NM, Siebelink E, Bots ML, et al.: Trans monounsaturated fatty acids and saturated fatty acids have similar effects on postprandial flow-mediated vasodilation. Eur J Clin Nutr 2002, 56:674–679.

    Article  PubMed  CAS  Google Scholar 

  24. Keogh JB, Grieger JA, Noakes M, et al.: Flow-mediated dilatation is impaired by a high-saturated fat diet but not by a high-carbohydrate diet. Arterioscler Thromb Vasc Biol 2005, 25:1274–1279.

    Article  PubMed  CAS  Google Scholar 

  25. Dyerberg J, Eskesen DC, Andersen PW, et al.: Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study. Eur J Clin Nutr 2004, 58:1062–1070.

    Article  PubMed  CAS  Google Scholar 

  26. Harvey KA, Arnold T, Rasool T, et al.: Trans-fatty acids induce pro-inflammatory responses and endothelial cell dysfunction. Br J Nutr 2008, 99:723–731.

    PubMed  CAS  Google Scholar 

  27. Kummerow FA, Zhou Q, Mahfouz MM: Effect of trans fatty acids on calcium influx into human arterial endothelial cells. Am J Clin Nutr 1999, 70:832–838.

    PubMed  CAS  Google Scholar 

  28. Zapolska-Downar D, Kosmider A, Naruszewicz M: Trans fatty acids induce apoptosis in human endothelial cells. J Physiol Pharmacol 2005, 56:611–625.

    PubMed  CAS  Google Scholar 

  29. Kavanagh K, Jones KL, Sawyer J, et al.: Trans fat diet induces abdominal obesity and changes in insulin sensitivity in monkeys [abstract]. Obesity 2007, 15:1675–1684.

    Article  PubMed  CAS  Google Scholar 

  30. Axen KV, Dikeakos A, Sclafani A: High dietary fat promotes Syndrome X in nonobese rats. J Nutr 2003, 133:2244–2249.

    PubMed  CAS  Google Scholar 

  31. Tetri LH, Basaranoglu M, Brunt EM, et al.: Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol 2008, 295:G987–G995.

    Article  PubMed  CAS  Google Scholar 

  32. Okada T, Noguchi R, Hosokawa M, et al.: Effects of trans and conjugated LC N-3 polyunsaturated fatty acids on lipid composition and abdominal fat weight in rats. J Food Sci 2008, 73:H201–H206.

    Article  PubMed  CAS  Google Scholar 

  33. Koh-Banerjee P, Chu NF, Spiegelman D, et al.: Prospective study of the association of changes in dietary intake, physical activity, alcohol consumption, and smoking with 9-y gain in waist circumference among 16,587 US men. Am J Clin Nutr 2003, 78:719–727.

    PubMed  CAS  Google Scholar 

  34. Field AE, Willett WC, Lissner L, et al.: Dietary fat and weight gain among women in the Nurses’ Health Study [abstract]. Obesity 2007, 15:967–976.

    Article  PubMed  Google Scholar 

  35. Christiansen E, Schnider S, Palmvig B, et al.: Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM. Diabetes Care 1997, 20:881–887.

    Article  PubMed  CAS  Google Scholar 

  36. Lefevre M, Lovejoy JC, Smith SR, et al.: Comparison of the acute response to meals enriched with cis- or trans-fatty acids on glucose and lipids in overweight individuals with differing FABP2 genotypes. Metabolism 2005, 54:1652–1658.

    Article  PubMed  CAS  Google Scholar 

  37. Vega-Lopez S, Ausman LM, Jalbert SM, et al.: Palm and partially hydrogenated soybean oils adversely alter lipoprotein profiles compared with soybean and canola oils in moderately hyperlipidemic subjects. Am J Clin Nutr 2006, 84:54–62.

    PubMed  CAS  Google Scholar 

  38. Louheranta AM, Turpeinen AK, Vidgren HM, et al.: A high-trans fatty acid diet and insulin sensitivity in young healthy women. Metabolism 1999, 48:870–875.

    Article  PubMed  CAS  Google Scholar 

  39. Lovejoy JC, Smith SR, Champagne CM, et al.: Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes Care 2002, 25:1283–1288.

    Article  PubMed  CAS  Google Scholar 

  40. Tardy AL, Lambert-Porcheron S, Malpuech-Brugere C, et al.: Dairy and industrial sources of trans fat do not impair peripheral insulin sensitivity in overweight women. Am J Clin Nutr 2009, Am J Clin Nutr 2009, 27:515.

    Google Scholar 

  41. Esmaillzadeh A, Azadbakht L: Consumption of hydrogenated versus nonhydrogenated vegetable oils and risk of insulin resistance and the metabolic syndrome among Iranian adult women. Diabetes Care 2008, 31:223–226.

    Article  PubMed  Google Scholar 

  42. Radesky JS, Oken E, Rifas-Shiman SL, et al.: Diet during early pregnancy and development of gestational diabetes. Paediatr Perinat Epidemiol 2008, 22:47–59.

    PubMed  Google Scholar 

  43. van Dam RM, Willett WC, Rimm EB, et al.: Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 2002, 25:417–424.

    Article  PubMed  Google Scholar 

  44. Meyer KA, Kushi LH, Jacobs DR, et al.: Dietary fat and incidence of type 2 diabetes in older Iowa women. Diabetes Care 2001, 24:1528–1535.

    Article  PubMed  CAS  Google Scholar 

  45. Salmeron J, Hu FB, Manson JE, et al.: Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001, 73:1019–1026.

    PubMed  CAS  Google Scholar 

  46. Roberts TL, Wood DA, Riemersma RA, et al.: Trans isomers of oleic and linoleic acids in adipose tissue and sudden cardiac death. Lancet 1995, 345:278–282.

    Article  PubMed  CAS  Google Scholar 

  47. Lemaitre RN, King IB, Raghunathan TE, et al.: Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation 2002, 105:697–701.

    Article  PubMed  CAS  Google Scholar 

  48. Lemaitre RN, King IB, Mozaffarian D, et al.: Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the Cardiovascular Health Study. Circulation 2006, 114:209–215.

    Article  PubMed  CAS  Google Scholar 

  49. Katz AM: Should trans fatty acids be viewed as membraneactive drugs? Atheroscler Suppl 2006, 7:41–42.

    Article  PubMed  CAS  Google Scholar 

  50. Katz AM, Nash-Adler P, Watras J, et al.: Fatty acid effects on calcium influx and efflux in sarcoplasmic reticulum vesicles from rabbit skeletal muscle. Biochim Biophys Acta 1982, 687:17–26.

    Article  PubMed  CAS  Google Scholar 

  51. Niu SL, Mitchell DC, Litman BJ: Trans fatty acid derived phospholipids show increased membrane cholesterol and reduced receptor activation as compared to their cis analogs. Biochemistry 2005, 44:4458–4465.

    Article  PubMed  CAS  Google Scholar 

  52. Morris MC, Evans DA, Tangney CC, et al.: Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Arch Neurol 2006, 63:1085–1088.

    Article  PubMed  Google Scholar 

  53. Williams MA, King IB, Sorensen TK, et al.: Risk of preeclampsia in relation to elaidic acid (trans fatty acid) in maternal erythrocytes. Gynecol Obstet Invest 1998, 46:84–87.

    Article  PubMed  CAS  Google Scholar 

  54. Mahomed K, Williams MA, King IB, et al.: Erythrocyte omega-3, omega-6 and trans fatty acids in relation to risk of preeclampsia among women delivering at Harare Maternity Hospital, Zimbabwe. Physiol Res 2007, 56:37–50.

    PubMed  CAS  Google Scholar 

  55. Mozaffarian D, Willett WC: Trans fatty acids and cardiovascular risk: a unique cardiometabolic imprint? Curr Atheroscler Rep 2007, 9:486–493.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dariush Mozaffarian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wallace, S.K., Mozaffarian, D. Trans-fatty acids and nonlipid risk factors. Curr Atheroscler Rep 11, 423–433 (2009). https://doi.org/10.1007/s11883-009-0064-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-009-0064-0

Keywords

Navigation